Yang Xiang to Gestational Trophoblastic Disease
This is a "connection" page, showing publications Yang Xiang has written about Gestational Trophoblastic Disease.
Connection Strength
1.306
-
Cheng H, Zong L, Kong Y, Wang X, Gu Y, Cang W, Zhao J, Wan X, Yang J, Xiang Y. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. Lancet Oncol. 2021 11; 22(11):1609-1617.
Score: 0.716
-
Wang W, Kong Y, Li Y, Wan X, Feng F, Ren T, Zhao J, Xiang Y, Yang J. Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2023 09 04; 33(9):1376-1382.
Score: 0.205
-
Jiang F, Mao MY, Xiang Y, Lu X, Guan CL, Jiao LZ, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial. BMC Cancer. 2023 Aug 23; 23(1):784.
Score: 0.204
-
Jiang F, Lin JK, Xiang Y, Xu ZF, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study. Eur J Cancer. 2022 01; 161:119-127.
Score: 0.181